Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors.
Year: 2020
Type: article
Source: PubMed
Institution: Northwell Health
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Award: Northwell Health NCORP
OpenAlex ID: W3116719695
